Weighing Cancer Cells for Personalized Myeloma Therapy with Clifford Reid, PhD, Travera
Clifford Reid, PhD and CEO of Travera shares a new approach to "personalized medicine" in multiple myeloma.
Increased Infection Risk in MGUS Patients
Myeloma Dental Care and Patients on Bisphosphonate Therapy
Atlanta Round Table - October 12, 2019
New Strategies to Improve CAR-T Therapies for Multiple Myeloma
A Reason Why Myeloma Patients Might Become Resistant to Bortezomib
Chicago Round Table - October 5, 2019
IMW 2019: The New GSK Antibody Drug Conjugate in Myeloma
Myeloma Crowd Launches a Psoriasis / Multiple Myeloma Study Using Its HealthTree® Platform
Muscles for Myeloma: Living a Normal Life
Muscles for Myeloma: Looking Forward
Delivering Targeted Radiotherapy to Myeloma Cells - CLR 131 with Natalie Callander, MD, University of Wisconsin
A new treatment is exploiting that difference by delivering a targeted therapy to just the cancer cells while avoiding the normal cells.
Seattle Round Table - September 28, 2019
IMW 2019: A Vaccine to Extend Myeloma Remissions with Syed Abbas Ali, MD
Muscles for Myeloma: Being Active by Pursuing Your Hobbies
Cannabis and Cancer Immunotherapy: Important Notes for Myeloma Patients
Can A Second Type of BCMA Multiple Myeloma Therapy Be Used After the First Fails?
The World's Largest Myeloma Screening Study (PROMISE) with Irene Ghobrial, MD, Dana Farber Cancer Institute
The PROMISE study is the world's largest screening study for multiple myeloma and is led by top myeloma researchers Dr. Irene Ghobrial and Dr. Ivan Borrello
MGUS Patients Can Progress to Multiple Myeloma In Just 5 Years
Minimal Residual Disease Testing in Multiple Myeloma
Keeping Track of Your Multiple Myeloma Medications
Miracles in Myeloma Development: Rare Success for a Rare Disease
When and How to Treat Smoldering Multiple Myeloma
Imaging Techniques in Multiple Myeloma
